Intrinsiqs

Is Altimmune, Inc. overvalued?

Altimmune, Inc. (ALT) — key valuation metrics and fundamentals.

No verdict
Price
$1.65
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$320.0M
Dividend yield
0.0%
Return on equity
-29.3%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ALT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.